glp-1 obesity drug news today september 2025 A new Medicare option for weight loss drugs: What older Americans should know GLP-1 Pipeline Update: August 2025

Buyer assumes all responsibility for safe handling and compliance with applicable laws

DDIT4 is involved in the protective modulation of AMSCs treating APAP-induced hepatotoxicity Next, we explored the potential mechanisms of how AMSCs treatment affects mitochondrial biogenesis and mitophagy

The three doses of GLP1/E led to a very significant reduction of body weight along the treatment period (Fig

This study highlights the potential role of miRNA in thyroid-hormone-regulated cholesterol metabolism

FIGURE 6 The supernatant and cells pellets were analyzed by LC-MS, and the extracellular and intracellular L-carnitine concentrations were determined (Figure 6B)